NeuroOne Medical Technologies Corporation (NMTC) Free cash flow 2019–2025
NeuroOne Medical Technologies Corporation (NMTC) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$2.9MFY2025 · since FY2019: -$5.5M → -$2.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$2.9M | +73.8% |
| FY2024 | -$11.1M | +16.1% |
| FY2023 | -$13.3M | -70.3% |
| FY2022 | -$7.8M | +10.1% |
| FY2021 | -$8.7M | -144.4% |
| FY2020 | -$3.5M | +35.0% |
| FY2019 | -$5.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice